North America Cardiac Rhythm Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers North America Cardiac Rhythm Management Companies and the market is segmented by product (defibrillators, pacemakers, and cardiac resynchronization therapy devices) and geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

North America Cardiac Rhythm Management Devices Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
North America Cardiac Rhythm Management Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 3.90 %
Market Concentration Medium

Major Players

North America Cardiac Rhythm Management Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

North America Cardiac Rhythm Management Devices Market Analysis

The North American cardiac rhythm management devices market is expected to witness a CAGR of 3.9% during the forecast period.

The COVID-19 pandemic significantly impacted market growth. The COVID-19 pandemic lockdown led to the suspension of non-urgent scheduled visits and hospitalizations, which resulted in the delayed diagnosis of patients with cardiac disorders. For instance, according to an article published in Heart Rhythm, in January 2022, about a 52.2% reduction in electrophysiology (EP) procedures, a 32.7% reduction in device procedures, and a 36.8% decrease in cardiac rhythm management (CRM) the referrals were observed during the pandemic period as compared to the pre-pandemic period in the United States. Moreover, an article published in PLOS One in August 2021 showed that the adjusted incident rate ratios for cardiovascular outcomes were considerably greater in the post-COVID-19 exposure period as compared to the pre-COVID-19. Thus, the long-term effects of COVID-19 on cardiovascular health raise the demand for cardiac management devices. Thus the market is anticipated to grow over the forecast period.

Factors such as the growing burden of cardiovascular diseases, technological advancements, and the rise in the use of ambulatory and home services for cardiac monitoring are expected to boost the market growth over the forecast period.

The increasing prevalence of cardiovascular diseases and technological advancements in the field of defibrillators are the major drivers for the market. For instance, as per the 2022 statistics published by AHA, more than 356,000 out-of-hospital cardiac arrests (OHCA) were reported in the United States annually, nearly 90% of them fatal. This leads to the high demand for cardiac rhythm management devices such as defibrillators as they are widely used in reviving patients from sudden cardiac arrest by providing sufficient oxygen and blood to the required organs via a sudden shock. This is anticipated to augment the market growth over the forecast period.

Additionally, the launch of various programs, awareness campaigns, and launch of automated external defibrillator management platforms to promote the importance of fully automated external defibrillators are also contributing to the market growth. For instance, in August 2022, Portage Health Foundation (PHF) announced a one-time automated external defibrillator (AED) grant program to address the foundation's long-term sustainability goal of building safer communities. Also, in August 2022, the Great Western Air Ambulance Charity team launched an automated external defibrillator (AED) usage campaign during CPR in the United States. Thus, the rising awareness programs for AED and increasing product launches by various government organizations are expected to contribute to the growth of the market.

Furthermore, the technological advancements in cardiac rhythm management devices, as well as the presence of key players in the region, are developing and launching products for helping patients with cardiovascular diseases, which is expected to augment the market growth over the forecast period. For instance, in December 2021, Boston Scientific began a clinical trial of its first modular cardiac rhythm implant system consisting of a leadless pacemaker and an implantable cardioverter defibrillator, two separate devices that work together to keep the heart from beating too fast or too slow. Also, in July 2021, Abbott launched Jot Dx, the latest insertable cardiac monitor (ICM). The technology allows for remote detection and improved diagnostic accuracy of cardiac arrhythmia in patients. Similarly, in July 2021, the United States Food and Drug Administration approved Medtronic's two AccuRhythm artificial intelligence (AI) algorithms for use with the LINQ II insertable cardiac monitor (ICM).

Therefore, owing to the factors such as the high burden of cardiovascular diseases, growing company activities, and rising technological advancements, the studied market is anticipated to grow over the forecast period. However, the high cost of devices and the effects of therapeutics radiation on implantable cardiac rhythm devices are likely to hinder the growth of the cardiac rhythm management devices market over the forecast period.

North America Cardiac Rhythm Management Devices Market Trends

Implantable Pacemaker Segment is Expected to Witness Significant Growth Over the Forecast Period

A pacemaker is a tiny device that uses electrical impulses and is implanted in the chest to assist in heartbeat regulation. It serves as a safeguard against the heart from beating too slowly. It can also control a fast heart rhythm and coordinate the chambers of the heart.

The implantable pacemakers (ICPS) segment is expected to witness significant growth in the cardiac rhythm management devices market over the forecast period owing to the factors such as the rising burden of cardiovascular diseases such as arrhythmias, heart failure, heart attack, and others. In addition, the growing geriatric population are more prone to develop cardiovascular diseases which is also expected to increase the demand for pacemakers, hence propelling the segment growth.

The rising product launches increase the availability of novel pacemaker devices which in turn is anticipated to fuel the segment growth over the forecast period. For instance, in February 2022, Abbott reported the first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. Also, in June 2021, the researchers at Northwestern and George Washington universities (GW) developed the first-ever transient pacemaker, a wireless, battery-free, fully implantable pacing device. All parts of the pacemaker are biocompatible and gradually dissolve over the course of five to seven weeks into the body's biofluids without the need for surgical removal. Similarly, in March 2022, Cleveland Clinic successfully implanted a dual-chamber leadless pacemaker system in the first patient in the United States as part of a global clinical trial, to offer heart rhythm patients a more targeted approach through a less invasive procedure with fewer complications.

Therefore, owing to the abovementioned factors the studied market is expected to grow over the forecast period.

North America Cardiac Rhythm Management Devices Market: Population Aged 65 Years or Above, (%), North America, 2022-2050

United States is Expected to Have the Significant Market Share Over the Forecast Period

The United States is expected to hold a significant share in the cardiac rhythm management devices market over the forecast period owing to the factors such as the high burden of cardiovascular diseases, increasing technological advancements, increasing healthcare expenditure, and growing demand for ambulatory or home services for cardiac monitoring.

The increasing prevalence of cardiovascular diseases is the key factor driving the demand for cardiac rhythm management devices in the country. For instance, according to the statistics published by AHA, in June 2021, an estimated more than 130 million adults in the United States are expected to have some type of heart disease by 2035. Thus, the high number of heart failure cases among the population increases the risk of atrial fibrillation and cardiac arrhythmias which requires regular monitoring of the heart rate, and oxygen saturation to prevent further risk to the heart that causes sudden death, hence propelling the demand for cardiac rhythm management devices in the country.

Additionally, as per a research study published in July 2021, it has been observed that about 6-12 million people in the United States are expected to suffer from atrial fibrillation by 2050, and 17.9 million people by 2060. Thus, the expected increase in the burden of cardiovascular-related health problems among the population is anticipated to fuel the demand for regular heart monitoring. This is expected to propel the market growth over the forecast period.

Furthermore, the growing company focuses on adopting various key strategies such as acquisitions, new product launches, and collaborations are also contributing to the market growth in the region. For instance, in April 2022, Abbott received the United States FDA approval for the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the United States with slow heart rhythms. A minimally invasive method is used to implant the Aveir leadless pacemaker inside the right ventricle of the heart to treat slower-than-normal heart rhythms. Also, in June 2021, AliveCor announced that the company has acquired the independent diagnostic testing facility (IDTF) CardioLabs, a leading monitoring, and cardiac diagnostic service provider. The acquisition is a cornerstone of AliveCor's mission to extend its comprehensive cardiological services to patients who are prescribed monitoring devices by their healthcare providers.

Therefore, owing to the abovementioned factors, such as the high burden of cardiovascular diseases, and growing company activities, the studied market is expected to grow over the forecast period.

North America Cardiac Rhythm Management Devices Market: Estimated Population Experiencing Atrial Fibrillation (in Million), United States,

North America Cardiac Rhythm Management Devices Industry Overview

The North American cardiac rhythm management devices market is highly competitive and consists of a few major players. Some of the key companies in the market include Abbott, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips NV, Medtronic PLC, SchillerAG, and Shenzhen Mindray Biomedical Electronics Co. Ltd.

North America Cardiac Rhythm Management Devices Market Leaders

  1. Biotronik SE & Co KG

  2. Boston Scientific Corporation

  3. Koninklijke Philips NV

  4. Medtronic PLC

  5. Abbott Laboratories

*Disclaimer: Major Players sorted in no particular order

North America Cardiac Rhythm Management Devices Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

North America Cardiac Rhythm Management Devices Market News

  • Nov 2022: Boston Scientific the LUX-Dx Insertable Cardiac Monitor (ICM) System, a long-term diagnostic device inserted under the skin of patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope in Europe.
  • Oct 2022: Medtronic PLC received the United States FDA approval for extended labeling of a cardiac lead that uses the heart's natural electrical system to deliver therapy to patients while avoiding complications.

North America Cardiac Rhythm Management Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Disorders
    • 4.2.2 Technological Advancements
    • 4.2.3 Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring
  • 4.3 Market Restraints
    • 4.3.1 Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices
    • 4.3.2 High Cost of Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 Product
    • 5.1.1 Defibrillators
    • 5.1.1.1 Implantable Cardioverter Defibrillators (ICDS)
    • 5.1.1.2 External Defibrillators (ED)
    • 5.1.2 Pacemakers
    • 5.1.2.1 Implantable Pacemakers (ICPS)
    • 5.1.2.2 External Pacemakers
    • 5.1.3 Cardiac Resynchronization Therapy Devices
    • 5.1.3.1 Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • 5.1.3.2 Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • 5.2 Geography
    • 5.2.1 United States
    • 5.2.2 Canada
    • 5.2.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Abiomed
    • 6.1.3 Biotronik SE & Co KG
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 LivaNova PLC
    • 6.1.7 Medtronic PLC
    • 6.1.8 SchillerAG
    • 6.1.9 Shenzhen Mindray Biomedical Electronics Co. Ltd
    • 6.1.10 Zoll Medical Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Cardiac Rhythm Management Devices Industry Segmentation

As per the scope of the report, Cardiac rhythm management is a part of electrophysiology, which is used to manage the functioning of the heart. The last decade has observed an ongoing evolution and the use of cardiac rhythm management devices, including cardiac resynchronization therapy, pacemakers, implantable cardioverter defibrillators, and loop recorders. General practitioners (GP) are increasingly involved in the follow-up and management of patients with these devices. 

The North American Cardiac Rhythm Management Devices Market is Segmented by Product (Defibrillators, Pacemakers, and Cardiac Resynchronization Therapy Devices) and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

Product Defibrillators Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators (ED)
Product Pacemakers Implantable Pacemakers (ICPS)
External Pacemakers
Product Cardiac Resynchronization Therapy Devices Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Geography United States
Canada
Mexico
Need A Different Region Or Segment?
Customize Now

North America Cardiac Rhythm Management Devices Market Research FAQs

The North America Cardiac Rhythm Management Devices Market is projected to register a CAGR of 3.9% during the forecast period (2024-2029)

Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, Medtronic PLC and Abbott Laboratories are the major companies operating in the North America Cardiac Rhythm Management Devices Market.

The report covers the North America Cardiac Rhythm Management Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Cardiac Rhythm Management Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

North America Cardiac Rhythm Management Devices Industry Report

Statistics for the 2023 North America Cardiac Rhythm Management Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Cardiac Rhythm Management Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

North America Cardiac Rhythm Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)